CAPSONI, SIMONA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.486
EU - Europa 11.896
AS - Asia 9.331
SA - Sud America 1.323
AF - Africa 221
Continente sconosciuto - Info sul continente non disponibili 54
OC - Oceania 16
Totale 40.327
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.187
IT - Italia 3.227
SG - Singapore 2.832
RU - Federazione Russa 2.482
CN - Cina 2.168
SE - Svezia 1.631
IE - Irlanda 1.260
KR - Corea 1.099
BR - Brasile 987
DE - Germania 925
TR - Turchia 760
VN - Vietnam 661
UA - Ucraina 626
HK - Hong Kong 573
GB - Regno Unito 489
FI - Finlandia 378
FR - Francia 273
BD - Bangladesh 246
IN - India 240
CA - Canada 172
CH - Svizzera 131
AR - Argentina 112
AT - Austria 104
JP - Giappone 94
IQ - Iraq 88
MX - Messico 72
ID - Indonesia 67
NL - Olanda 67
PK - Pakistan 67
IL - Israele 66
VE - Venezuela 66
ZA - Sudafrica 61
BE - Belgio 56
PH - Filippine 56
PL - Polonia 55
SA - Arabia Saudita 54
ES - Italia 53
EU - Europa 47
EC - Ecuador 45
UZ - Uzbekistan 45
CO - Colombia 43
MY - Malesia 32
AE - Emirati Arabi Uniti 29
MA - Marocco 29
AL - Albania 26
EG - Egitto 26
CL - Cile 24
TN - Tunisia 21
KE - Kenya 19
JO - Giordania 17
LT - Lituania 17
TW - Taiwan 16
PE - Perù 15
PY - Paraguay 15
DZ - Algeria 14
JM - Giamaica 14
CZ - Repubblica Ceca 13
TH - Thailandia 13
AU - Australia 12
RS - Serbia 12
AZ - Azerbaigian 11
NP - Nepal 11
DK - Danimarca 10
ET - Etiopia 10
LB - Libano 10
PS - Palestinian Territory 10
KZ - Kazakistan 9
LU - Lussemburgo 9
CR - Costa Rica 8
NI - Nicaragua 8
OM - Oman 8
BN - Brunei Darussalam 7
HU - Ungheria 7
RO - Romania 7
UY - Uruguay 7
BO - Bolivia 6
PA - Panama 6
DO - Repubblica Dominicana 5
GE - Georgia 5
PT - Portogallo 5
TT - Trinidad e Tobago 5
AO - Angola 4
BG - Bulgaria 4
BW - Botswana 4
IR - Iran 4
KG - Kirghizistan 4
LY - Libia 4
MD - Moldavia 4
MN - Mongolia 4
NG - Nigeria 4
SN - Senegal 4
XK - ???statistics.table.value.countryCode.XK??? 4
ZW - Zimbabwe 4
BH - Bahrain 3
BY - Bielorussia 3
HN - Honduras 3
KH - Cambogia 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
SY - Repubblica araba siriana 3
Totale 40.262
Salva come PNG Salva come JPEG
Città #
Pisa 2.204
Ashburn 1.726
Dallas 1.714
Singapore 1.541
San Jose 1.383
Chandler 1.373
Jacksonville 1.304
Dublin 1.257
Seoul 1.089
Boardman 857
Council Bluffs 645
Moscow 579
Izmir 533
Wilmington 527
Hong Kong 518
Hefei 413
Ann Arbor 399
The Dalles 375
Boston 310
Los Angeles 280
New York 280
Beijing 267
Millbury 264
Düsseldorf 227
Munich 215
Kent 193
Mestre 188
Ho Chi Minh City 183
San Mateo 181
Lauterbourg 170
Istanbul 164
Hanoi 158
Helsinki 141
Ogden 121
Seattle 120
Bremen 119
Milan 108
Bern 107
Princeton 106
Santa Clara 96
Washington 96
North Bergen 94
Vienna 93
Lawrence 92
Woodbridge 88
São Paulo 86
Toronto 82
Chicago 81
Frankfurt am Main 76
Buffalo 75
Orem 75
Tokyo 74
Guangzhou 69
San Paolo di Civitate 67
Saint Petersburg 63
Shanghai 61
Rome 59
Columbus 56
Dearborn 53
Turku 53
Brussels 51
Chennai 51
Holon 51
Warsaw 47
London 42
Montreal 41
Wuhan 41
Dong Ket 39
Brooklyn 38
Denver 38
Scuola 38
Da Nang 37
Amsterdam 36
Tashkent 36
Baghdad 35
Jakarta 34
Atlanta 33
Houston 32
Stockholm 32
Dhaka 29
Mexico City 28
San Giuliano Terme 28
Johannesburg 27
Rio de Janeiro 27
Belo Horizonte 26
Fairfield 26
Haiphong 26
Caracas 25
Las Vegas 25
Norwalk 23
San Francisco 23
Brasília 22
Nanjing 22
Poplar 22
Lahore 21
Jeddah 20
Manchester 20
Mumbai 20
Ankara 19
Florence 19
Totale 25.178
Salva come PNG Salva come JPEG
Nome #
Initial events leading to ß amyloid expression in anti-NGF transgenic mice. 2.643
2-Bromomelatonin: synthesis and characterization of a potent melatonin agonist 445
The contribution of early inflammation to neurodegeneration in anti-Nerve Growth Factor mice 396
Enteric Alpha-synuclein inclusions, colonic inflammation, increased mucosal permeability and alterations of Bowel neuromuscular functiond precede central neurodegeneration in a transgenic mouse model of Parkinson's disease 388
(2008) Receptor for Advanced Glycation End Product-Dependent Activation of p38 Mitogen-Activated Protein Kinase Contributes to Amyloid-ß-Mediated Cortical Synaptic Dysfunction 383
The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor 375
Graphene promotes axon elongation through local stall of Nerve Growth Factor signaling endosomes 344
A new mechanism for Alzheimer neurodegeneration: functional antagonism between proNGF, mature NGF and their receptors 331
NGF steers microglia toward a neuroprotective phenotype 330
Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons 318
A dual mechanism linking NGF/proNGF imbalance and early inflammation to Alzheimer's disease neurodegeneration in the AD11 anti-NGF mouse model 313
Enteric alpha-synuclein accumulation impairs intestinal epithelial barrier through inflammasome activation before the onset of brain pathology in a transgenic mouse model of Parkinson's disease 304
The positional identity of mouse ES cell-generated neurons is affected by BMP signaling. 296
Congenital pain insensitivity mutation in nerve growth factor gene uncouples nociception from central features of pain in heterozygous humans and mice 293
Intranasal "painless" Human Nerve Growth Factors Slows Amyloid Neurodegeneration and Prevents Memory Deficits in App X PS1 Mice 293
Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice 292
A new generation of NGF-based therapy for Alzheimer’s disease 290
Amyloid plaque-independent deficit of early postnatal visual cortical plasticity in the 5xFAD transgenic model of Alzheimer's disease. 285
The NGFR100W Mutation Specifically Impairs Nociception without Affecting Cognitive Performance in a Mouse Model of Hereditary Sensory and Autonomic Neuropathy Type V 281
A small molecule targeting the multifactorial nature of Alzheimer's disease 280
A new generation of non invasive NGF-based therapies for Alzheimer’s Disease 279
Alzheimer-like neurodegeneration in anti-Nerve Growth Factor transgenic mice 279
Abeta-Dependent Inhibition of LTP in Different Intra-Cortical Circuits of the Visual Cortex: The role of RAGE 273
Pathogen Free Conditions Slow the Onset of Neurodegeneration in a Mouse Model of Nerve Growth Factor Deprivation 272
Environmental enrichment prevents the onset of memory deficits and reduces neuropathological hallmarks in a mouse model of Alzheimer-like neurodegeneration 272
COMPOSIZIONI IN GRADO DI PREVENIRE EVENTI NEURODEGENERATIVI E METODO PER SAGGIARNE L'ATTIVITA' 271
A carnivore species (Canis familiaris) expresses circadian melatonin rhythm in the peripheral blood and melatonin receptors in the brain 269
Acute cholinergic rescue of synaptic plasticity in the neurodegenerating cortex of anti-nerve-growth-factor mice 265
Alzheimer-like neurodegeneration in aged anti-nerve growth factor mice 258
A microglial function for the nerve growth factor : predictions of the unpredictable 250
Targeting the cation-chloride co-transporter NKCC1 to re-establish GABAergic inhibition and an appropriate excitatory/inhibitory balance in selective neuronal circuits: a novel approach for the treatment of Alzheimer's disease 250
ProNGF/NGF inbalance triggers neurodegeneration in transgenic mice. 249
Over-expression of furin-resistant pro-NGF determines neurodegeneration in transgenic mice 249
Abeta (1-42) impairs LTP in mous eneocortex through RAGE mediated activation of p38 MAP kinase 248
Human TrkAR649W mutation impairs nociception, sweating and cognitive abilities : a mouse model of HSAN IV 246
Intranasal administration of a painless human NGF reduces memory deficit and amyloid oligomers accumulation in APPxPS1 mice 245
Identification of proNGF versus NGF expression fingerprinting in PC12 cells 245
ANIMALI TRANSGENICI NON UMANI ANTI-NGF 244
ProNGFNGF imbalance triggers learning and memory deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic mice 243
Functional Characterization of Human ProNGF and NGF Mutants: Identification of NGF P61SR100E as a "Painless" Lead Investigational Candidate for Therapeutic Applications 243
MUTEINS OF HNGF, THERAPEUTIC USES AND PHARMACEUTICAL COMPOSITIONS 239
Delivery of NGF to the Brain: Intranasal Versus Ocular Administration in Anti-NGF Transgenic Mice 239
Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson's disease before brain pathology 238
Alzheimer-like neurodegeneration in aged anti-Nerve Growth Factor (NGF) mice 234
Environmental enrichment rescues visual memory deficits in a mouse model of Alzheimer disease 231
An unbalance of proNGF/NGF signalling determines AD-like neurodegeneration in mice. 230
Nerve Growth Factor regulates astrocyte physiology in vivo 227
Effects of the cholinesterase inhibitor galantamine in a mouse model of Alzheimer's disease, the anti-nerve growth factor AD11 transgenic mice 227
Reversal of neurological deficits by painless nerve growth factor in a mouse model of Rett syndrome 225
Role of NGF in modulating adult neurogenesis in ALzheimer's disease mouse model 224
Failure of nicotine-dependent enhancement of synaptic efficacy at Schaffer-collateral CA1 synapses of AD11 anti-nerve growth factor transgenic mice 223
Gene expression biomarkers in the brain of a mouse model for Alzheimer's disease: mining of microarray data by logic classification and feature selection 222
Ganstigmine and donepezil improve neurodegeneration in AD11 antinerve growth factor transgenic mice 222
Effects of cholinesterase inhibitor galantamine in a mouse model of Alzheimer disease, the anti-NGF AD11 mice 222
Intranasal administration of an optimized human Nerve Growth Factor reduces memory deficits and amyloid oligomers accumulation in APPxPS1 mice 221
Reduced levels of NGF shift astrocytes toward a neurotoxic phenotype 215
IN VITRO RECEPTOR BINDING PROPERTIES OF A "PAINLESS" NGF MUTEIN, LINKED TO HEREDITARY SENSORY AUTONOMIC NEUROPATHY TYPE V 215
Amelioration of the neurodegenerative phenotype in AD11 anti-NGF mice 215
Autoradiographic localization of putative melatonin receptors in the brains of two old world primates: Cercopithecus aethiops and Papio ursinus 214
ProNGF Drives Localized and Cell Selective Parvalbumin Interneuron and Perineuronal Net Depletion in the Dentate Gyrus of Transgenic Mice 214
Development of a non-invasive NGF-based therapy for Alzheimer's disease. Current Alzheimer Research 6: 158 211
Localization and characterization of melatonin binding sites in the brain of the rabbit (Oryctolagus cuniculus) by autoradiography and in vitro ligand-receptor binding 210
Transgenic mice with chronic NGF deprivation and Alzheimer's disease-like pathology display hippocampal region-specific impairments in short- and long-term plasticities 209
Involvement of NGF in early stages of chick embryo development 209
On the molecular basis linking Nerve Growth Factor (NGF) to Alzheimer’s disease 206
Nerve Growth Factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice 205
The role of Nerve Growth Factor in development and in ALzheimer's disease 205
Intranasal delivery of therapeutic proteins for neurological diseases 205
Delivery of NGF to the brain: intranasal versus ocular administration in anti-NGF transgenic mice. J Alzheimers Dis 16: 371 204
Role of NGF in modulating adult neurogenesis in an Alzheimer's disease mouse model 201
Rat visual cortical neurones express TrkA NGF receptor 200
Taking pain out of NGF: a "painless" NGF mutant, linked to hereditary sensory autonomic neuropathy type V, with full neurotrophic activity. 200
Neutralization of nerve growth factor impairs proliferation and differentiation of adult neural progenitors in the subventricular zone 197
From genes to pain: nerve growth factor and hereditary sensory and autonomic neuropathy type V 196
Memoquin: a new compound to attack Alzheimer disease on multiple fronts 193
PHENOTYPIC KNOCKOUT OF NERVE GROWTH FACTOR IN ADULT TRANSGENIC MICE REVEALS SEVERE DEFICITS IN BASAL FOREBRAIN CHOLINERGIC NEURONS, CELL DEATH IN THE SPLEEN, AND SKELETAL MUSCLE DYSTROPHY 190
Peripheral Neutralization of Nerve Growth Factor Induces Immunosympathectomy and Central Neurodegeneration in Transgenic Mice 189
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 188
Long-term memantine treatment prevents behavioral deficits in a mouse model of sporadic Alzheimer's disease 188
Interaction between NH2-tau fragment and Aß in AD mitochondria contributes to the synaptic deterioration 188
Nerve growth factor regulates axial rotation during early stages of chick embryo development 186
Memoquin: A new therapeutic poly-agent for Alzheimer's disease 186
BDNF intranasal administration rescues visual memory deficits in a mouse model of Alzheimer disease (AD), the AD11 mouse 185
COMPOSITIONS ABLE TO PREVENT NEURODEGENERATIVE PROCESSES AND METHODS OF ASSAYING THE SAME 183
Long-term memantine treatment prevents behaviour deficits in a mouse model of sporadic Alzheimer's disease 181
Understanding pain perception through genetic painlessness diseases : the role of NGF and proNGF 180
Intranasal delivery of BDNF rescues memory deficits in AD11 mice and reduces brain microgliosis 180
Environmental enrichment rescues visual memory deficits in a mouse model of Alzheimer disease after the onset of neurodegeneration 179
Identification of a caspase-derived N-terminal tau fragment in cellular and animal Alzheimer's disease models 179
Early involvement of inflammation and immune response mRNAs in the brain of anti-Nerve Growth Factor AD11 mice, as revealed by gene expression profiling 179
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 178
Autoradiographic quantification of endothelin ET(A)receptors in peripheral and brain arteries of the rat 178
Expression of the melatonin receptors in Xenopus laevis 178
Postnatal development of GFAP in mouse visual cortex is not affected by light deprivation 177
The richness of the environment bidirectionally affects the progression of the disease in a mous emodel of Alzheimer's disease, the AD11 mice 176
Antagonization of NGF in adult mice by transgenic antibodies causes progressive learning and memory impairments 175
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 174
Endogenous Aβ causes cell death via early tau hyperphosphorylation 174
Distribution and characterization of the melatonin receptors in the hypothalamus and pituitary gland of three domestic ungulates 173
Morphological basis for pineal secretion in domestic Ungulata 173
Totale 26.095
Salva come PNG Salva come JPEG
Categoria #
all - tutte 184.419
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 184.419
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021276 0 0 0 0 0 0 0 0 0 0 0 276
2021/20221.470 141 14 11 78 99 19 31 127 92 76 71 711
2022/20236.174 413 377 260 427 382 599 4 1.562 1.850 33 124 143
2023/20241.921 268 47 215 47 137 388 72 106 209 72 10 350
2024/20258.746 1.665 292 269 738 904 180 590 335 1.265 430 983 1.095
2025/202615.822 937 1.444 2.167 1.435 1.029 660 2.670 957 2.197 1.134 715 477
Totale 40.612